Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 93 articles:
HTML format
Text format



Single Articles


    April 2017
  1. BONGIOVANNI M, Mermod M, Canberk S, Saglietti C, et al
    Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Cancer. 2017 Apr 3. doi: 10.1002/cncy.21860.
    PubMed     Text format     Abstract available


  2. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Text format     Abstract available


    March 2017
  3. HAJEK M, Sewell A, Kaech S, Burtness B, et al
    TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30570.
    PubMed     Text format     Abstract available


  4. CHEN T, Zhang J, Chen Z, Van Waes C, et al
    Genetic alterations in TRAF3 and CYLD that regulate nuclear factor kappaB and interferon signaling define head and neck cancer subsets harboring human papillomavirus.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30659.
    PubMed     Text format    


  5. BRANDLER TC, Zhou F, Liu CZ, Cho M, et al
    Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Cancer. 2017 Mar 10. doi: 10.1002/cncy.21848.
    PubMed     Text format     Abstract available


    February 2017
  6. LIU Z, Chang ET, Liu Q, Cai Y, et al
    Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30643.
    PubMed     Text format     Abstract available


  7. GRABOYES EM, Garrett-Mayer E, Sharma AK, Lentsch EJ, et al
    Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30651.
    PubMed     Text format     Abstract available


  8. ZEVALLOS JP, Mazul AL
    The complex relation between race, sex, and human papillomavirus status in head and neck cancer.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30619.
    PubMed     Text format    


  9. HUANG J, Fogg M, Wirth LJ, Daley H, et al
    Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
    Cancer. 2017 Feb 21. doi: 10.1002/cncr.30541.
    PubMed     Text format     Abstract available



  10. Immunotherapy drug improves survival for patients with head and neck cancer.
    Cancer. 2017;123:545.
    PubMed     Text format    


  11. TABERNA M, Inglehart RC, Pickard RK, Fakhry C, et al
    Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer.
    Cancer. 2017 Feb 14. doi: 10.1002/cncr.30564.
    PubMed     Text format     Abstract available


  12. ZHAO L, Dias-Santagata D, Sadow PM, Faquin WC, et al
    Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21839.
    PubMed     Text format     Abstract available


  13. GAN TR, Nga ME, Lum JH, Wong WM, et al
    Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21823.
    PubMed     Text format     Abstract available


  14. GRABOYES EM, Zhan KY, Garrett-Mayer E, Lentsch EJ, et al
    Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2017 Feb 9. doi: 10.1002/cncr.30586.
    PubMed     Text format     Abstract available


  15. MANYAM BV, Garsa AA, Chin RI, Reddy CA, et al
    A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2017 Feb 7. doi: 10.1002/cncr.30601.
    PubMed     Text format     Abstract available


  16. YEN YC, Chang JH, Lin WC, Chiou JF, et al
    Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Cancer. 2017 Feb 2. doi: 10.1002/cncr.30565.
    PubMed     Text format     Abstract available


    January 2017
  17. WONG TH, Skanthakumar T, Nadkarni N, Nguyen HV, et al
    Survival of patients with head and neck squamous cell carcinoma by housing subsidy in a tiered public housing system.
    Cancer. 2017 Jan 30. doi: 10.1002/cncr.30557.
    PubMed     Text format     Abstract available


  18. JABBOUR J, Milross C, Sundaresan P, Ebrahimi A, et al
    Education and support needs in patients with head and neck cancer: A multi-institutional survey.
    Cancer. 2017 Jan 12. doi: 10.1002/cncr.30535.
    PubMed     Text format     Abstract available


  19. CHUANG SL, Su WW, Chen SL, Yen AM, et al
    Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers.
    Cancer. 2017 Jan 5. doi: 10.1002/cncr.30517.
    PubMed     Text format     Abstract available


    December 2016
  20. PEZZI TA, Mohamed AS, Sheu T, Blanchard P, et al
    Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30493.
    PubMed     Text format     Abstract available


  21. ZUMSTEG ZS, Kim S, David JM, Yoshida EJ, et al
    Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30508.
    PubMed     Text format     Abstract available


  22. PENG H, Chen L, Li WF, Guo R, et al
    Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30520.
    PubMed     Text format     Abstract available


  23. RAMAKODI MP, Devarajan K, Blackman E, Gibbs D, et al
    Integrative genomic analysis identifies ancestry-related expression quantitative trait loci on DNA polymerase beta and supports the association of genetic ancestry with survival disparities in head and neck squamous cell carcinoma.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30457.
    PubMed     Text format     Abstract available


  24. BAUMAN JE, Cohen E, Ferris RL, Adelstein DJ, et al
    Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30449.
    PubMed     Text format     Abstract available


    October 2016
  25. TAJUDEEN BA, Taylor ZD, Garritano J, Cheng H, et al
    Dynamic optical contrast imaging as a novel modality for rapidly distinguishing head and neck squamous cell carcinoma from surrounding normal tissue.
    Cancer. 2016 Oct 20. doi: 10.1002/cncr.30338.
    PubMed     Text format     Abstract available


  26. STOKES WA, Jones BL, Bhatia S, Oweida AJ, et al
    A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.
    Cancer. 2016 Oct 11. doi: 10.1002/cncr.30382.
    PubMed     Text format     Abstract available


    September 2016
  27. TAYLOR LJ, Greenberg CC, Lidor AO, Leverson GE, et al
    Utilization of surgical treatment for local and locoregional esophageal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2016 Sep 28. doi: 10.1002/cncr.30368.
    PubMed     Text format     Abstract available


  28. BEADLE BM, Liao KP, Giordano SH, Garden AS, et al
    Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Cancer. 2016 Sep 23. doi: 10.1002/cncr.30350.
    PubMed     Text format     Abstract available


  29. CHAU NG, Haddad RI
    Antiangiogenic agents in head and neck squamous cell carcinoma: Tired of going solo.
    Cancer. 2016 Sep 20. doi: 10.1002/cncr.30352.
    PubMed     Text format    


  30. JIMENO A, Posner MR, Wirth LJ, Saba NF, et al
    A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Sep 20. doi: 10.1002/cncr.30317.
    PubMed     Text format     Abstract available


    August 2016
  31. MAZUL AL, Taylor JM, Divaris K, Weissler MC, et al
    Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
    Cancer. 2016 Aug 29. doi: 10.1002/cncr.30312.
    PubMed     Text format     Abstract available


  32. JIMENO A, Machiels JP, Wirth L, Specenier P, et al
    Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30256.
    PubMed     Text format     Abstract available


  33. WARD MC, Reddy CA, Adelstein DJ, Koyfman SA, et al
    Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis.
    Cancer. 2016 Aug 9. doi: 10.1002/cncr.30214.
    PubMed     Text format     Abstract available


  34. NAGHAVI AO, Echevarria MI, Grass GD, Strom TJ, et al
    Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30212.
    PubMed     Text format     Abstract available


    July 2016
  35. DIVI V, Harris J, Harari PM, Cooper JS, et al
    Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30204.
    PubMed     Text format     Abstract available


    June 2016
  36. YIN LX, Ha PK
    Genetic alterations in salivary gland cancers.
    Cancer. 2016;122:1822-31.
    PubMed     Text format     Abstract available


  37. GARDEN AS, Fuller CD, Rosenthal DI, William WN Jr, et al
    Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2016;122:1702-7.
    PubMed     Text format     Abstract available


  38. WEISS J, Grilley Olson J, Deal AM, Chera B, et al
    Using the galactose-alpha-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab.
    Cancer. 2016;122:1697-701.
    PubMed     Text format     Abstract available


    May 2016
  39. LIN CC, Fedewa SA, Prickett KK, Higgins KA, et al
    Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.
    Cancer. 2016 May 31. doi: 10.1002/cncr.30122.
    PubMed     Text format     Abstract available


  40. WEISS JM, Bagley S, Hwang WT, Bauml J, et al
    Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma.
    Cancer. 2016 May 19. doi: 10.1002/cncr.30067.
    PubMed     Text format     Abstract available


  41. RETTIG EM, D'Souza G, Thompson CB, Koch WM, et al
    Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    Cancer. 2016 May 16. doi: 10.1002/cncr.30005.
    PubMed     Text format     Abstract available


  42. BIRON VL, Kostiuk M, Isaac A, Puttagunta L, et al
    Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Cancer. 2016;122:1544-51.
    PubMed     Text format     Abstract available


  43. CRACCHIOLO JR, Baxi SS, Morris LG, Ganly I, et al
    Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cancer. 2016;122:1523-32.
    PubMed     Text format     Abstract available


  44. BELL D, Bell AH, Bondaruk J, Hanna EY, et al
    In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
    Cancer. 2016;122:1513-22.
    PubMed     Text format     Abstract available


  45. PATEL MA, Blackford AL, Rettig EM, Richmon JD, et al
    Rising population of survivors of oral squamous cell cancer in the United States.
    Cancer. 2016;122:1380-7.
    PubMed     Text format     Abstract available


  46. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Text format     Abstract available


    March 2016
  47. KUO P, Sosa JA, Burtness BA, Husain ZA, et al
    Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2016 Mar 28. doi: 10.1002/cncr.29962.
    PubMed     Text format     Abstract available


  48. AMINI A, Jones BL, McDermott JD, Serracino HS, et al
    Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29956.
    PubMed     Text format     Abstract available


  49. ROBERTS TJ, Colevas AD, Hara W, Holsinger FC, et al
    Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29932.
    PubMed     Text format     Abstract available


  50. SONG YS, Lim JA, Choi H, Won JK, et al
    Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29934.
    PubMed     Text format     Abstract available


  51. PRINTZ C
    Developments in precision medicine: Studies highlight new applications for cancer chemoprevention, treatment.
    Cancer. 2016;122:661-2.
    PubMed     Text format    


  52. ARMENIAN SH, Bhatia S
    Looking back to inform the future: Lesson learned from survivors of childhood cancer.
    Cancer. 2016;122:678-80.
    PubMed     Text format    


  53. FRIEDMAN DN, Chou JF, Oeffinger KC, Kleinerman RA, et al
    Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
    Cancer. 2016;122:773-81.
    PubMed     Text format     Abstract available


  54. MOR V, Joyce NR, Cote DL, Gidwani RA, et al
    The rise of concurrent care for veterans with advanced cancer at the end of life.
    Cancer. 2016;122:782-90.
    PubMed     Text format     Abstract available


    February 2016
  55. MCDOWELL LJ, Young RJ, Johnston ML, Tan TJ, et al
    p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    Cancer. 2016 Feb 16. doi: 10.1002/cncr.29901.
    PubMed     Text format     Abstract available


  56. PAN JJ, Ng WT, Zong JF, Chan LL, et al
    Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Cancer. 2016;122:546-58.
    PubMed     Text format     Abstract available


  57. FRAKES JM, Naghavi AO, Demetriou SK, Strom TJ, et al
    Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Cancer. 2016;122:634-41.
    PubMed     Text format     Abstract available


  58. CAPOZZI LC, McNeely ML, Lau HY, Reimer RA, et al
    Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: Results from an exploratory randomized controlled exercise trial.
    Cancer. 2016 Feb 1. doi: 10.1002/cncr.29863.
    PubMed     Text format     Abstract available


    January 2016
  59. PRASAD ML, Vyas M, Horne MJ, Virk RK, et al
    NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Cancer. 2016 Jan 19. doi: 10.1002/cncr.29887.
    PubMed     Text format     Abstract available


    December 2015
  60. LIN SH, Zhang N, Godby J, Wang J, et al
    Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
    Cancer. 2015 Dec 30. doi: 10.1002/cncr.29857.
    PubMed     Text format     Abstract available


  61. VERDONCK-DE LEEUW IM, Cuijpers P, Leemans CR
    Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29850.
    PubMed     Text format    


  62. ROH JL, Kim SA
    Reply to pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29849.
    PubMed     Text format    


    November 2015
  63. XING Y, Zhang J, Lin H, Gold KA, et al
    Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Cancer. 2015 Nov 10. doi: 10.1002/cncr.29780.
    PubMed     Text format     Abstract available


  64. JIN LX, Moley JF
    Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Cancer. 2015 Nov 5. doi: 10.1002/cncr.29761.
    PubMed     Text format     Abstract available


    October 2015
  65. SCHENKER Y, Arnold RM, Bauman JE, Heron DE, et al
    An enhanced role for palliative care in the multidisciplinary approach to high-risk head and neck cancer.
    Cancer. 2015 Oct 27. doi: 10.1002/cncr.29754.
    PubMed     Text format    


  66. WANG W, Su X, He K, Wang Y, et al
    Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Cancer. 2015 Oct 27. doi: 10.1002/cncr.29689.
    PubMed     Text format     Abstract available


  67. QIAN G, Jiang N, Wang D, Newman S, et al
    Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Cancer. 2015;121:3600-11.
    PubMed     Text format     Abstract available


  68. LAGERGREN J, Andersson G, Talback M, Drefahl S, et al
    Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site.
    Cancer. 2015 Oct 8. doi: 10.1002/cncr.29731.
    PubMed     Text format     Abstract available



  69. Iyer NG, Tan DSW, Tan VK, Wang W, Hwang J, Tan N-C, Sivanandan R, Tan H-K., Lim WT, Ang M-K, Wee J, Soo K-C and Tan EH. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmeta
    Cancer. 2015;121:3560.
    PubMed     Text format    


  70. DAHLSTROM KR, Li G, Hussey CS, Vo JT, et al
    Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Cancer. 2015;121:3455-64.
    PubMed     Text format     Abstract available


    September 2015
  71. KIM SA, Roh JL, Lee SA, Lee SW, et al
    Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Cancer. 2015 Sep 15. doi: 10.1002/cncr.29693.
    PubMed     Text format     Abstract available


  72. JENSEN AD, Nikoghosyan AV, Poulakis M, Hoss A, et al
    Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
    Cancer. 2015;121:3001-9.
    PubMed     Text format     Abstract available


    August 2015
  73. WANG LY, Roman BR, Migliacci JC, Palmer FL, et al
    Cost-effectiveness analysis of papillary thyroid cancer surveillance.
    Cancer. 2015 Aug 17. doi: 10.1002/cncr.29633.
    PubMed     Text format     Abstract available


  74. HARA W, Le QT
    Individualizing treatment for patients with nasopharyngeal cancer.
    Cancer. 2015;121:2671-3.
    PubMed     Text format    


  75. KEAM B, Kim SB, Shin SH, Cho BC, et al
    Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma.
    Cancer. 2015;121:2612-7.
    PubMed     Text format     Abstract available


  76. KEANE FK, Chen YH, Neville BA, Tishler RB, et al
    Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Cancer. 2015;121:2594-602.
    PubMed     Text format     Abstract available


    July 2015
  77. SAWKA AM, Straus S, Rodin G, Heus L, et al
    Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.
    Cancer. 2015 Jul 20. doi: 10.1002/cncr.29548.
    PubMed     Text format     Abstract available


  78. XU L, Tang H, Chen DW, El-Naggar AK, et al
    Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.
    Cancer. 2015;121:2367-74.
    PubMed     Text format     Abstract available


    June 2015
  79. CASTRO MR, Morris JC, Ryder M, Brito JP, et al
    Most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance.
    Cancer. 2015 Jun 16. doi: 10.1002/cncr.29468.
    PubMed     Text format    


  80. NILUBOL N, Kebebew E
    Reply to most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance.
    Cancer. 2015 Jun 16. doi: 10.1002/cncr.29467.
    PubMed     Text format    


  81. MAO L, Clark D
    Molecular margin of surgical resections--where do we go from here?
    Cancer. 2015;121:1914-6.
    PubMed     Text format    


  82. GRAHAM DM, Isaranuwatchai W, Habbous S, de Oliveira C, et al
    A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.
    Cancer. 2015;121:1785-92.
    PubMed     Text format     Abstract available


  83. SINHA P, Piccirillo JF, Kallogjeri D, Spitznagel EL, et al
    The role of postoperative chemoradiation for oropharynx carcinoma: a critical appraisal of the published literature and National Comprehensive Cancer Network guidelines.
    Cancer. 2015;121:1747-54.
    PubMed     Text format     Abstract available


    May 2015
  84. DEEKEN JF, Wang H, Subramaniam D, He AR, et al
    A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies.
    Cancer. 2015;121:1645-53.
    PubMed     Text format     Abstract available


  85. LEWIS CM, Monroe MM, Roberts DB, Hessel AC, et al
    An audit and feedback system for effective quality improvement in head and neck surgery: Can we become better surgeons?
    Cancer. 2015;121:1581-7.
    PubMed     Text format     Abstract available


  86. ROSENTHAL DI, Mohamed AS, Weber RS, Garden AS, et al
    Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
    Cancer. 2015;121:1608-19.
    PubMed     Text format     Abstract available


  87. ZHANG M, Qureshi AA, Fortner RT, Hankinson SE, et al
    Teenage acne and cancer risk in US women: A prospective cohort study.
    Cancer. 2015;121:1681-7.
    PubMed     Text format     Abstract available


    April 2015
  88. CABANILLAS ME, Schlumberger M, Jarzab B, Martins RG, et al
    A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.
    Cancer. 2015 Apr 24. doi: 10.1002/cncr.29395.
    PubMed     Text format     Abstract available


    March 2015
  89. GUO T, Qualliotine JR, Ha PK, Califano JA, et al
    Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Cancer. 2015 Mar 17. doi: 10.1002/cncr.29323.
    PubMed     Text format     Abstract available


  90. REUSCHENBACH M, Huebbers CU, Prigge ES, Bermejo JL, et al
    Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
    Cancer. 2015 Mar 2. doi: 10.1002/cncr.29315.
    PubMed     Text format     Abstract available


    February 2015
  91. HO AS, Davies L, Nixon IJ, Palmer FL, et al
    Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates.
    Cancer. 2015 Feb 24. doi: 10.1002/cncr.29289.
    PubMed     Text format     Abstract available


    January 2015
  92. WIEBEL JL, Banerjee M, Muenz DG, Worden FP, et al
    Trends in imaging after diagnosis of thyroid cancer.
    Cancer. 2015 Jan 6. doi: 10.1002/cncr.29210.
    PubMed     Text format     Abstract available


    November 2014
  93. NILUBOL N, Kebebew E
    Should small papillary thyroid cancer be observed? A population-based study.
    Cancer. 2014 Nov 25. doi: 10.1002/cncr.29123.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: